Centene (NYSE:CNC) will issue its quarterly earnings data before the market opens on Tuesday, April 23rd. Analysts expect the company to announce earnings of $1.32 per share for the quarter. Centene has set its FY 2019 guidance at $4.11-4.31 EPS and its FY19 guidance at $8.22-8.62 EPS.Parties that wish to register for the company’s conference call can do so using this link.
Centene (NYSE:CNC) last released its quarterly earnings data on Tuesday, February 5th. The company reported $1.38 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.33 by $0.05. Centene had a net margin of 1.50% and a return on equity of 14.10%. The business had revenue of $16.56 billion for the quarter, compared to analysts’ expectations of $16.38 billion. During the same quarter last year, the company earned $0.49 EPS. The company’s revenue for the quarter was up 29.3% compared to the same quarter last year. On average, analysts expect Centene to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.
CNC stock opened at $48.20 on Monday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.00 and a current ratio of 1.00. Centene has a fifty-two week low of $45.44 and a fifty-two week high of $74.49. The stock has a market capitalization of $19.92 billion, a P/E ratio of 13.62, a PEG ratio of 0.85 and a beta of 1.26.
In related news, EVP Christopher D. Bowers sold 9,200 shares of the stock in a transaction dated Friday, February 15th. The shares were sold at an average price of $65.01, for a total value of $598,092.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 2.50% of the company’s stock.
CNC has been the topic of a number of analyst reports. Cowen initiated coverage on shares of Centene in a report on Thursday, February 28th. They issued an “outperform” rating and a $77.00 price objective on the stock. Oppenheimer decreased their target price on shares of Centene from $165.00 to $83.00 and set an “outperform” rating for the company in a research report on Wednesday, February 6th. Stephens initiated coverage on shares of Centene in a research report on Monday, January 14th. They issued an “overweight” rating and a $73.50 target price for the company. ValuEngine lowered shares of Centene from a “hold” rating to a “sell” rating in a research report on Friday, February 8th. Finally, Jefferies Financial Group reiterated a “buy” rating and issued a $76.00 target price on shares of Centene in a research report on Thursday, February 7th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $76.87.
Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. The company's Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which covers dually eligible individuals, as well as aged, blind, or disabled programs.
Featured Story: Dollar Cost Averaging
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.